NCT07568483

Brief Summary

Background: Tobacco smoking and vaping remains public health concern, with many adults continuing to experience difficulties accessing appropriate support for smoking cessation in Switzerland and Türkiye. Structural barriers, including stigma related to attempting to quit, limited financial and time resources, low awareness of the health risks associated with tobacco smoking- and vaping-reduce engagement with traditional services. TUBSIS 2.0 aims to address these access inequities by providing a fully remote, anonymous and free internet-based program tailored to diverse adult populations in both countries. Objectives: The "TUBSIS 2.0: An Adaptation Study of Tobacco Addiction Support Programme - TUBSIS for Tobacco Users in Switzerland and Türkiye" project aims to support readiness to reduce or quit tobacco smoking/vaping, improve well-being and self-compassion and strengthen health-related behaviors. The intervention targets German-, English-, and Turkish-speaking adults and includes mindfulness-based strategies for quitting or reducing tobacco smoking and vaping. Motivation to cease tobacco smoking/vaping varies considerably across the lifespan. Younger individuals may perceive smoking/vaping cessation as unnecessary, often due to limited awareness of long-term health risks or a sense of invulnerability. In later adulthood, although addiction tends to be more deeply established, many individuals hesitate to attempt cessation because of concerns about the psychological and behavioral challenges associated with the process. It is therefore essential to provide individuals with support that helps them understand the cessation process, prepare for the challenges that can be expected and identify strategies that align with their psychological needs. Such strategies may include stress management and self-compassion practices that can be utilized before, during and after cessation attempts. TUBSIS 2.0 offers structured and accessible guidance to support this preparation by providing a clear, evidence-based pathway for individuals at different stages of readiness to change. Methods: TUBSIS 2.0 is a web-based, individual and asynchronous program consisting of eight modules delivered over four weeks. A total of 406 participants will be recruited and randomly assigned to either the intervention or control group. Data are collected anonymously at four measurement points (baseline, mid-term, post-term and 8-week follow-up) from participants. The program focuses on supporting participants' reducing or quitting tobacco smoking or vaping; to increase their readiness for smoking/vaping cessation, mental well-being, self-compassion and stress management with mindfulness strategies. Within the Health Action Process Approach (HAPA), the process of behaviour change is conceptualised as a dynamic, non-linear process that progresses through motivational and volitional phases. TUBSIS 2.0 has been adapted to reflect this structure by integrating phase-specific components. These components include modules that enhance risk awareness and outcome expectancies, planning and self-regulation tools to support action initiation and mindfulness-based strategies that are embedded throughout all phases to strengthen self-efficacy and coping. By addressing these shifting needs across the change process, the programme provides a responsive and theory-driven pathway for reducing/quitting tobacco smoking or vaping. Relevance: TUBSIS 2.0 is highly relevant to public health priorities, as it provides a cost-effective, scalable and environmentally sustainable intervention that eliminates barriers commonly associated with traditional cessation services. By requiring no travel, printed materials or in-person appointments, the programme offers equitable access to adults across all age groups, genders and diverse migrant communities in Switzerland and Türkiye. Its multilingual and culturally adapted structure addresses significant service gaps for populations that are underserved or hesitant to seek conventional support. By reducing tobacco smoking- or vaping-related harm and facilitating early behavioural change, TUBSIS 2.0 has the potential to decrease long-term healthcare costs while expanding access to evidence-based digital prevention tools.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
406

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Nov 2025Aug 2026

Study Start

First participant enrolled

November 15, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 5, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

April 22, 2026

Last Update Submit

April 30, 2026

Conditions

Keywords

smoking tobaccovapingweb-based interventionmindfulnessHealth Action Process Approach

Outcome Measures

Primary Outcomes (2)

  • 7-day point prevalence abstinence

    Self-reported abstinence from smoking/vaping (not having smoked/vaped even one puff in the past 7 days).

    4 weeks (post-intervention) + 4 weeks (follow-up without intervention)

  • Cigarette/vapor consumption

    Change in cigarette/vapor consumption measured as number of cigarettes smoked or vaping per day for daily smokers and frequency and quantity of smoking for occasional smokers.

    4 weeks (post-intervention) + 4 weeks (follow-up without intervention)

Secondary Outcomes (4)

  • Stage of behavior change

    4 weeks (post-intervention) + 4 weeks

  • Mental well-being

    4 weeks (post-intervention) + 4 weeks (follow-up without intervention)

  • Nicotine dependence (Fagerström Test for Nicotine Dependence)

    4 weeks (post-intervention) + 4 weeks (follow-up without intervention)

  • Nicotine dependence (Electronic Fagerström Test for Nicotine Dependence)

    4 weeks (post-intervention) + 4 weeks (follow-up without intervention)

Study Arms (2)

TUBSIS 2.0 Intervention

EXPERIMENTAL

Participants receive immediate access to the TUBSIS 2.0 web-based behavioral intervention program designed to support "smoking tobacco use or vaping reduction" through psychoeducation, mindfulness and behavior change techniques.

Behavioral: TUBSIS 2.0

Waitlist Control

NO INTERVENTION

Participants are assigned to a waitlist control group and receive access to the intervention after a defined follow-up period.

Interventions

TUBSIS 2.0BEHAVIORAL

A web-based, asynchronous behavioral intervention program integrating psychoeducation, mindfulness, and behavior change techniques to support tobacco and e-cigarette use reduction. The program consists of structured modules delivered over a four-week period and includes exercises targeting self-regulation, craving management, and motivation for behavior change.

TUBSIS 2.0 Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18 years or older
  • Smoking status:
  • Smoked on ≥1 day in the past 30 days, and/or Smoked at least 100 cigarettes in lifetime
  • Internet access: Stable internet connection and access to a smartphone, tablet, or computer during interaction of the TUBSIS 2.0 web-based platform.
  • Language: Sufficient reading and listening comprehension in the study language (German, English or Turkish)
  • Contact: Valid email address and phone number (optional) for study communication, reminders and incentive payments
  • Consent: Provided electronic informed consent on TUBSIS 2.0 web-based platform which is developed and administrated by ISGF.
  • Study procedures: Agreement to randomization (intervention or control) and completion of study assessments at four time points (baseline, mid-intervention, post-intervention and 8-week follow-up)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Swiss Research Institute for Public Health and Addiction - ISGF (Schweizer Institut für Sucht- und Gesundheitsforschung)

Zurich, 8005, Switzerland

RECRUITING

Related Links

MeSH Terms

Conditions

Tobacco Use DisorderVapingSmoking

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersBehavior

Study Officials

  • Michael Schaub, Prof. Dr. phil.

    Swiss Research Institute for Public Health and Addiction - ISGF, University of Zurich

    PRINCIPAL INVESTIGATOR
  • Inci Derya Yücel, Dr. phil.

    Swiss Research Institute for Public Health and Addiction - ISGF, University of Zurich

    STUDY DIRECTOR

Central Study Contacts

Michael Schaub, Prof. Dr. phil.

CONTACT

Inci Derya Yücel, Dr. phil.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study. Participants are aware of their group assignment due to the nature of the behavioral intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized into an intervention group receiving immediate access to the TUBSIS 2.0 program and a waitlist control group receiving access after a follow-up period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. phil.

Study Record Dates

First Submitted

April 22, 2026

First Posted

May 5, 2026

Study Start

November 15, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to data protection regulations and the sensitive nature of the collected data.

Locations